Almudena Chaves-Perez

6PUBLICATIONS
73CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 23, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.

Clemens Hinterleitner, Valentin J A Barthet, Hailey V Goldberg

|Apr 29, 2025
A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma.

Caroline Broderick, Riccardo Mezzadra, Exequiel M Sisso

|Jan 10, 2025
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia.

Scott E Millman, Almudena Chaves-Perez, Sudha Janaki-Raman

|Nov 10, 2022
Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer.

Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli

|Sep 13, 2022
Transit-amplifying cells control R-spondins in the mouse crypt to modulate intestinal stem cell proliferation.

Almudena Chaves-Pérez, Karla Santos-de-Frutos, Sergio de la Rosa

|Jun 01, 2019
URI is required to maintain intestinal architecture during ionizing radiation.

Almudena Chaves-Pérez, Mahmut Yilmaz, Cristian Perna

Pageof 1

Frequent Collaborators

4 joint publications

Scott W Lowe

3 joint publications

Riccardo Mezzadra

3 joint publications

Yu-Jui Ho

2 joint publications

Valentin J A Barthet